3.8(Q2)
CiteScore
27
h-index

Evaluation of Anti-Asthmatic Potential of Emblica Officinalis Seed Extract in RAW 264.7 Cell Lines

Document Type : Original Research Article

Authors

1 Faculty of Pharmacy, Karpagam Academy of Higher Education, Coimbatore- 641 105, Tamil Nadu, India

2 Department of Pharmacognosy, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris- 643001, Tamil Nadu, India

10.48309/ajgc.2026.553890.1848
Abstract
This study aims to explore the anti-asthmatic potential of Emblica officinalis seed extract by assessing its effect on inflammatory markers in RAW 264.7 cell line. The preliminary evaluation of Emblica officinalis seed extract performed and characterized by UV, HPLC, and GCMS. Molecular docking was carried out using Schrodinger. DPPH, ABTS, and nitric oxide production were determined to study antioxidant effects, and cytotoxicity was assessed by MTT assay. The expression of IL-4, IL-13, TNF-alpha in LPS induced RAW 264.7 cell lines was analyzed using FACS method. The hydroalcoholic extract produced an extractive and ash values of 2.85% w/w and 3.47 ± 0.15% w/w, respectively. The determination of total phenolic and flavonoid content was favorable. The characterization of the extract was performed and analyzed through HPLC chromatograms. The GCMS chromatogram showed peaks at various retention times indicating the presence of phytoconstituents. In silico studies showed good interactions between selected ligands and the target proteins. The antioxidant studies proved that the extract possesses free radical scavenging activity, reduces nitric oxide production, and MDA levels. The extract proved to be non-toxic in the MTT assay. In LPS induced RAW 264.7 cells the expression of the target proteins that actively involved in the pathogenesis of asthma was decreased.

Graphical Abstract

Evaluation of Anti-Asthmatic Potential of Emblica Officinalis Seed Extract in RAW 264.7 Cell Lines

Keywords

Subjects


©2026 The author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

PUBLISHER NOTE

Sami Publishing Company remains neutral concerning jurisdictional claims in published maps and institutional affiliations.

CURRENT PUBLISHER

Sami Publishing Company

[1] Olsthoorn, S.E., van Krimpen, A., Hendriks, R.W., Stadhouders, R. Chronic inflammation in asthma: Looking beyond the th2 cell. Immunological Reviews, 2025, 330(1), e70010.
[2] Croisant, S. Epidemiology of asthma: Prevalence and burden of disease. Heterogeneity in Asthma, 2013, 17-29.
[3] Pastore, D., Lupia, C., D’Amato, M., Bruni, A., Garofalo, E., Longhini, F., Gallelli, L., Vatrella, A., Pelaia, G., Pelaia, C. Emerging biological treatments for asthma. Expert Opinion on Emerging Drugs, 2025, 30(2), 87-97.
[4] Sihombing, J.L., Gea, S., Wirjosentono, B., Agusnar, H., Pulungan, A.N., Herlinawati, H., Yusuf, M., Hutapea, Y.A. Characteristic and catalytic performance of Co and Co-Mo metal impregnated in Sarulla natural zeolite catalyst for hydrocracking of MEFA rubber seed oil into biogasoline fraction. Catalysts, 2020, 10, 121.
[6] Jin H J. Biological treatments for severe Asthma. Yeungnam University Journal of Medicine, 2020, 37(4), 262–268.
[7] Diamant, Z., Jesenak, M., Hanania, N.A., Heaney, L.G., Djukanovic, R., Ryan, D., Quirce, S., Backer, V., Gaga, M., Pavord, I., Antolín-Amérigo, D. EUFOREA pocket guide on the diagnosis and management of asthma: an educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients. Respiratory Medicine, 2023, 218, 107361.
[8] Schramm, B., Ehlken, B., Smala, A., Quednau, K., Berger, K., Nowak, D. Cost of illness of atopic asthma and seasonal allergic rhinitis in germany: 1‐yr retrospective study. European Respiratory Journal, 2003, 21(1), 116-122.
[9] Spergel, J.M., Paller, A.S. Atopic dermatitis and the atopic march. Journal of Allergy and Clinical Immunology, 2003, 112(6), S118-S127.
[10] O'connell, E. The burden of atopy and asthma in children. Allergy, 2004, 59, 7-11.
[11] Ismaila, A.S., Sayani, A.P., Marin, M., Su, Z. Clinical, economic, and humanistic burden of asthma in canada: A systematic review. BMC Pulmonary Medicine, 2013, 13(1), 70.
[12] Berger, P. Physiopathologie de l’asthme sévère: Quelles cibles moléculaires pour les biothérapies? Bulletin de l'Académie Nationale de Médecine, 2023, 207(5), 605-611.
[13] Yang, Y., Jia, M., Ou, Y., Adcock, I.M., Yao, X. Mechanisms and biomarkers of airway epithelial cell damage in asthma: A review. The Clinical Respiratory Journal, 2021, 15(10), 1027-1045.
[14] Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention (Workshop Report), 2006.
[16] Hambly, N., Nair, P. Monoclonal antibodies for the treatment of refractory asthma. Current Opinion in Pulmonary Medicine, 2014, 20(1), 87-94.
[17] Pelaia, C., Heffler, E., Crimi, C., Maglio, A., Vatrella, A., Pelaia, G., Canonica, G.W. Interleukins 4 and 13 in asthma: Key pathophysiologic cytokines and druggable molecular targets. Frontiers in Pharmacology, 2022, 13, 851940.
[18] Shankar, A., McAlees, J.W., Lewkowich, I.P. Modulation of il-4/il-13 cytokine signaling in the context of allergic disease. Journal of Allergy and Clinical Immunology, 2022, 150(2), 266-276.
[19] Moran, A., Pavord, I.D. Anti-il-4/il-13 for the treatment of asthma: The story so far. Expert Opinion on Biological Therapy, 2020, 20(3), 283-294.
[20] Habib, N., Pasha, M.A., Tang, D.D. Current understanding of asthma pathogenesis and biomarkers. Cells, 2022, 11(17), 2764.
[21] Vimala, Y., Rachel, K.V., Pramodini, Y., Umasankar, A. Usage of indian gooseberry (Emblica officinalis) seeds in health and disease. Nuts and Seeds in Health and Disease Prevention, 2011, 663-670.
[22] Govind, P., Pandey, S. Phytochemical and toxicity study of Emblica officinalis (amla). International Research Journal of Pharmacy, 2011, 2(3), 270-272.
[23] Dogra, K.S., Chauhan, S., Jalal, J.S. Assessment of indian medicinal plants for the treatment of asthma. Journal of Medicinal Plants Research, 2015, 9(32), 851-862.
[24] Dasaroju, S., Gottumukkala, K.M. Current trends in the research of Emblica officinalis (amla): A pharmacological perspective. Internationa Journal of Pharmaceutical Sciences Review and Research, 2014, 24(2), 150-159.
[25] Khandelwal, K.R. Practical pharmacognosy. Book, 2008.
[26] Faruq, M.O., Rahim, A., Arifuzzaman, M., Ghosh, G.P. Phytochemicals screening, nutritional assessment and antioxidant activities of a. Viridis l. And a. Spinosus l. Leaves: A comparative study. Journal of Agriculture and Food Research, 2024, 18, 101341.
[27] Gupta, S., Basavan, D., Nataraj, S.K.M., Raju, K.R.S., Babu, U., LM, S.K., Gupta, R. Assessment of inhibitory potential of pothos scandens l. On ovalbumin-induced airway hyperresponsiveness in BALB/C mice. International Immunopharmacology, 2014, 18(1), 151-162.
[28] Trease, G., Evans, W. Pharmacognosy. Brailliar tiridel and macmillian publishers. London, uk. 1989.
[29] Balamurugan, V., Fatima, S., Velurajan, S. A guide to phytochemical analysis. International Journal of Advance Research and Innovative Ideas in Education, 2019, 5(1), 236-245.
[30] Arawande, J.O., Akinnusotu, A., Alademeyin, J.O. Extractive value and phytochemical screening of ginger (zingiber officinale) and turmeric (curcuma longa) using different solvents. International Journal of Tradational and Natural Medicines, 2018, 8(1), 13-22.
[31] Abbas, A., Naqvi, S.A.R., Rasool, M.H., Noureen, A., Mubarik, M.S., Tareen, R.B. Phytochemical analysis, antioxidant and antimicrobial screening of seriphidium oliverianum plant extracts. Dose-response, 2021, 19(1), 15593258211004739.
[32] Khalid, M., Amayreh, M., Sanduka, S., Salah, Z., Al-Rimawi, F., Al-Mazaideh, G.M., Alanezi, A.A., Wedian, F., Alasmari, F., Shalayel, M.H.F. Assessment of antioxidant, antimicrobial, and anticancer activities of sisymbrium officinale plant extract. Heliyon, 2022, 8(9).
[34] Priyadharshini, S., Swaroop, A.K., Jubie, S., Jawahar, N., Divecha, V. Molecular docking and cytotoxicity interactions of naringenin and its nano-structured lipid carriers in erα positive breast cancer. Indian Journal of Biochemistry and Biophysics (IJBB), 2023, 60(2), 141-147.
[35] Yamauchi, M., Kitamura, Y., Nagano, H., Kawatsu, J., Gotoh, H. DPPH measurements and structure—activity relationship studies on the antioxidant capacity of phenols. Antioxidants, 2024, 13(3), 309.
[36] Schlesier, K., Harwat, M., Böhm, V., Bitsch, R. Assessment of antioxidant activity by using different in vitro methods. Free Radical Research, 2002, 36(2), 177-187.
[37] Silva, F., Veiga, F., Cardoso, C., Dias, F., Cerqueira, F., Medeiros, R., Paiva-Santos, A.C. A rapid and simplified dpph assay for analysis of antioxidant interactions in binary combinations. Microchemical Journal, 2024, 202, 110801.
[38] Lang, Y., Gao, N., Zang, Z., Meng, X., Lin, Y., Yang, S., Yang, Y., Jin, Z., Li, B. Classification and antioxidant assays of polyphenols: A review. Journal of Future Foods, 2024, 4(3), 193-204.
[39] Yan, H., Hou, W., Lei, B., Liu, J., Song, R., Hao, W., Ning, Y., Zheng, M., Guo, H., Pan, C. Ultrarobust stable abts radical cation prepared using spore@ cu-tma biocomposites for antioxidant capacity assay. Talanta, 2024, 276, 126282.
[40] Sriklung, K., Apiratikul, N., Samosorn, S., Narkwichean, A., Watanapokasin, R. Lupalbigenin inhibiting nf-κb translocation associated with anti-inflammatory responses in lipopolysaccharide stimulated raw 264.7 macrophages. Journal of the Medical Association of Thailand, 2022, 105.
[41] Ilaghi, M., Sharifi, I., Sharififar, F., Sharifi, F., Oliaee, R.T., Babaei, Z., Meimamandi, M.S., Keyhani, A., Bamorovat, M. The potential role and apoptotic profile of three medicinal plant extracts on leishmania tropica by mtt assay, macrophage model and flow cytometry analysis. Parasite Epidemiology and Control, 2021, 12, e00201.
[42] Moon, H.R., Chung, M.J., Park, J.W., Cho, S.M., Choi, D.J., Kim, S.M., Chun, M.H., Kim, I.B., Kim, S.O., Jang, S.J., Park, Y.I. Antiasthma effects through anti-inflammatory action of acorn (Quercus acutissima Carr.) in vitro and in vivo. Journal of Food Biochemistry, 2013, 37(1), 108–118.
[43] Joo, T., Sowndhararajan, K., Hong, S., Lee, J., Park, S.Y., Kim, S., Jhoo, J.W. Inhibition of nitric oxide production in lps-stimulated raw 264.7 cells by stem bark of ulmus pumila l. Saudi Journal of Biological Sciences, 2014, 21(5), 427-435.
[44] Achoui, M., Appleton, D., Abdulla, M.A., Awang, K., Mohd, M.A., Mustafa, M.R. In vitro and in vivo anti-inflammatory activity of 17-o-acetylacuminolide through the inhibition of cytokines, nf-κb translocation and ikkβ activity. PloS one, 2010, 5(12), e15105.
[45] Taira, J., Nanbu, H., Ueda, K. Nitric oxide-scavenging compounds in agrimonia pilosa ledeb on lps-induced raw264. 7 macrophages. Food Chemistry, 2009, 115(4), 1221-1227.
[46] Tian, Y., Zhou, S., Takeda, R., Okazaki, K., Sekita, M., Sakamoto, K. Anti-inflammatory activities of amber extract in lipopolysaccharide-induced raw 264.7 macrophages. Biomedicine & Pharmacotherapy, 2021, 141, 111854.
[47] Mas-Bargues, C., Escriva, C., Dromant, M., Borras, C., Vina, J. Lipid peroxidation as measured by chromatographic determination of malondialdehyde. Human plasma reference values in health and disease. Archives of Biochemistry and Biophysics, 2021, 709, 108941.
[48] Ghonimi, N.A., Elsharkawi, K.A., Khyal, D.S., Abdelghani, A.A. Serum malondialdehyde as a lipid peroxidation marker in multiple sclerosis patients and its relation to disease characteristics. Multiple Sclerosis and Related Disorders, 2021, 51, 102941.
[49] Ahmad, G., Hassan, R., Dhiman, N., Ali, A. Assessment of anti-inflammatory activity of 3-acetylmyricadiol in lpsstimulated raw 264.7 macrophages. Combinatorial Chemistry & High Throughput Screening, 2022, 25(1), 204-210.
[50] Sornsenee, P., Chatatikun, M., Mitsuwan, W., Kongpol, K., Kooltheat, N., Sohbenalee, S., Pruksaphanrat, S., Mudpan, A., Romyasamit, C. Lyophilized cell-free supernatants of lactobacillus isolates exhibited antibiofilm, antioxidant, and reduces nitric oxide activity in lipopolysaccharide-stimulated raw 264.7 cells. PeerJ, 2021, 9, e12586.
[51] Yoon, S.B., Lee, Y.J., Park, S.K., Kim, H.C., Bae, H., Kim, H.M., Ko, S.G., Choi, H.Y., Oh, M.S., Park, W. Anti-inflammatory effects of Scutellaria baicalensis water extract on LPS-activated RAW 264.7 macrophages. Journal of Ethnopharmacology, 2009, 125(2), 286–290.
[52] Kwon, O.K., Lee, M.Y., Yuk, J.E., Oh, S.R., Chin, Y.W., Lee, H.K., Ahn, K.S. Anti-inflammatory effects of methanol extracts of the root of Lilium lancifolium on LPS-stimulated RAW264.7 cells. Journal of Ethnopharmacology, 2010, 130(1), 28–34.
[54] Monga, S., Fares, B., Yashaev, R., Melamed, D., Kahana, M., Fares, F., Weizman, A., Gavish, M. The effect of natural-based formulation (NBF) on the response of raw264. 7 macrophages to LPS as an in vitro model of inflammation. Journal of Fungi, 2022, 8(3), 321.
[55] Khirallah, S.M., Ramadan, H.M., Shawky, A., Qahl, S.H., Baty, R.S., Alqadri, N., Alsuhaibani, A.M., Jaremko, M., Emwas, A.-H., Saied, E.M. Development of novel 1, 3-disubstituted-2-thiohydantoin analogues with potent anti-inflammatory activity; in vitro and in silico assessments. Molecules, 2022, 27(19), 6271.
[56] Zhao, G., Zhang, T., Ma, X., Jiang, K., Wu, H., Qiu, C., Guo, M., Deng, G. Oridonin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-induced raw264. 7 cells and acute lung injury. Oncotarget, 2017, 8(40), 68153.
[57] Hu, X.D., Yang, Y., Zhong, X.G., Zhang, X.H., Zhang, Y.N., Zheng, Z.P., Zhou, Y., Tang, W., Yang, Y.F., Hu, L.H. Anti-inflammatory effects of z23 on lps-induced inflammatory responses in raw264. 7 macrophages. Journal of Ethnopharmacology, 2008, 120(3), 447-451.
[58] Jeon, C.M., Shin, I.S., Shin, N.R., Hong, J.M., Kwon, O.K., Kim, H.S., Oh, S.R., Myung, P.K., Ahn, K.S. Siegesbeckia glabrescens attenuates allergic airway inflammation in lps-stimulated raw 264.7 cells and ova induced asthma murine model. International immunopharmacology, 2014, 22(2), 414-419.
[59] Lee, J.W., Seo, K.H., Ryu, H.W., Yuk, H.J., Park, H.A., Lim, Y., Ahn, K.S., Oh, S.R. Anti-inflammatory effect of stem bark of paulownia tomentosa steud. In lipopolysaccharide (lps)-stimulated raw264. 7 macrophages and lps-induced murine model of acute lung injury. Journal of Ethnopharmacology, 2018, 210, 23-30.
[60] Amaral-Machado, L., Oliveira, W.N., Moreira-Oliveira, S.S., Pereira, D.T., Alencar, E.N., Tsapis, N., Egito, E.S.T. Use of natural products in asthma treatment. Evidence‐Based Complementary and Alternative Medicine, 2020, 2020(1), 1021258.
[61] Bagnasco, D., Ferrando, M., Varricchi, G., Passalacqua, G., Canonica, G.W. A critical evaluation of anti-il-13 and anti-il-4 strategies in severe asthma. International Archives of Allergy and Immunology, 2016, 170(2), 122-131.

Articles in Press, Accepted Manuscript
Available Online from 26 January 2026

  • Receive Date 18 October 2025
  • Revise Date 21 November 2025
  • Accept Date 22 January 2026